4 December 2013
Microgen plc (the "Company")
Notifiable Interests
The Company received the following notice on 4 December 2013 in compliance with the Disclosure and Transparency Rules from The Wellcome Trust Limited:
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
|
||||
1. Identity of the issuer or the underlying issuer |
MICROGEN PLC |
||||
2 Reason for the notification (please tick the appropriate box or boxes): |
|||||
An acquisition or disposal of voting rights |
|
||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||||
An event changing the breakdown of voting rights |
X |
||||
Other (please specify): |
|
|
|||
3. Full name of person(s) subject to the |
The Wellcome Trust Limited, as Trustee of The Wellcome Trust |
||||
4. Full name of shareholder(s) |
As above
|
||||
5. Date of the transaction and date on |
2nd December 2013 |
||||
6. Date on which issuer notified: |
4th December 2013 |
||||
7. Threshold(s) that is/are crossed or |
Crossed 5% |
||||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
GBP0.05 GB0005869531 |
4,038,879 |
4,038,879 |
4,038,879 |
4,038,879 |
|
5.42 |
|
|||||||||
|
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
4,038,879 |
5.42% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
|
|
14. Contact name: |
Christopher Weston |
|
15. Contact telephone number: |
0207 611 8665 |
|
If you require further information please contact:
Anjum O'Neill, Company Secretary, Microgen plc Tel: 020 7496 8100